ArticleOncotarget2015

Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER).

Shao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.